Akaal Life Sciences Private Limited
About Akaal Life Sciences Private Limited
Data last updated:
Akaal Life Sciences Private Limited is a private limited company based in Mohali, Punjab, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 June 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24290PB2019PTC049609.
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Manmohan Singh Grewal and Mankirat Kaur.
Its last annual general meeting (AGM) was held on 30 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sector 53, Mohali, Punjab.
As per the financials filed for FY 2025, the company reported a revenue of ₹31,157, a decline of 14% compared to the previous year. For the same year it recorded a net loss of ₹5.56 Lakh and EBITDA of -₹7.5 Lakh. Revenue has declined at a compounded annual rate (CAGR) of 7% over three years.
As per MCA filings, the company has open charges of ₹6.78 Lakh on record.
Company details
Contact details
Akaal Life Sciences Private Limited's registered office is in Mohali, Punjab. Its e-mail address is in the company report.
- Email
- Registered AddressHouse No. 638 Phase 3A, Sector 53, Mohali, Punjab, India – 160059
- IndustryPharma, Drug Formulation & Development, API Manufacturers
To see the full contact details of Akaal Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Akaal Life Sciences Private Limited
FY 2025 filings availableAkaal Life Sciences Private Limited reported revenue of ₹31,157 (down 14% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 7% over three years, including a 14% fall in the latest year. EBITDA rose 33% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹7.5 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹5.56 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Akaal Life Sciences Private Limited, buy the company report.
Board of directors of Akaal Life Sciences Private Limited
Akaal Life Sciences has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manmohan Singh Grewal | Director | 12 Jun 2019 | 7 Years 5 Months | Current |
| Mankirat Kaur | Director | 12 Jun 2019 | 7 Years 5 Months | Current |
Peer comparison
Akaal Life Sciences Private Limited is compared with the 10 companies closest to it by revenue in the Healthcare industry (API Manufacturers, Ayurvedic Products and Services, Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Adwins Healthcare Private Limited | ₹32,600 (FY 2021) | -97.0% | Rohtak, Haryana, India | |||
| Wright Care Remedies Private Limited | ₹32,000 (FY 2024) | Jaipur, Rajasthan, India | ||||
| Jewal Pharmaceutical Private Limited | ₹32,000 (FY 2025) | 1771.0% | Ahmedabad, Gujarat, India | |||
| Medamos Life Sciences Private Limited | ₹31,945 (FY 2024) | Bangalore, Karnataka, India | ||||
| Indoor Biotechnologies India Private Limited | ₹31,480 (FY 2023) | -100.0% | Bangalore, Karnataka, India | |||
| Akaal Life Sciences Private Limitedthis company | ₹31,157 (FY 2025) | -₹5.56 Lakh | -14.0% | Mohali, Punjab, India | ||
| Baldwin Pharmaceuticals Private Limited | ₹31,063 (FY 2022) | -58.0% | Jammu, Jammu and Kashmir, India | |||
| Marshall Hospital Private Limited | ₹31,022 (FY 2025) | -93.0% | New Delhi, Delhi, India | |||
| Sunvill Healthcare Private Limited | ₹31,000 (FY 2023) | Baddi, Himachal Pradesh, India | ||||
| Chaitanya Ayurveda Private Limited | ₹30,891 (FY 2025) | -45.0% | Lucknow, Uttar Pradesh, India | |||
| Apg Needles Pvt Ltd | ₹30,738 (FY 2024) | -100.0% | New Delhi, Delhi, India |
To see the full peer comparison of Akaal Life Sciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 03 Jul 2020 | 100351065 | The Hongkong and Shanghai Banking Corporation Limited | ₹6.78 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Akaal Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Akaal Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Akaal Life Sciences Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Akaal Life Sciences Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Mankirat Kaur was appointed as Director on 12 Jun 2019.
Frequently asked questions
Akaal Life Sciences is an active private limited company based in Mohali, Punjab, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 June 2019 (7+ years old) and is registered under CIN U24290PB2019PTC049609.
Akaal Life Sciences has 2 current directors:
- Manmohan Singh Grewal - Director
- Mankirat Kaur - Director
The latest financial statements of Akaal Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 August 2025. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Akaal Life Sciences is U24290PB2019PTC049609. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Akaal Life Sciences was incorporated on 12 June 2019, making it 7+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Akaal Life Sciences by revenue are Adwins Healthcare Private Limited, Wright Care Remedies Private Limited, Jewal Pharmaceutical Private Limited, Medamos Life Sciences Private Limited, Indoor Biotechnologies India Private Limited and 5 more, all in the Healthcare industry (API Manufacturers, Ayurvedic Products and Services, Formulations).
Mankirat Kaur was appointed as Director on 12 Jun 2019. Manmohan Singh Grewal was appointed as Director on 12 Jun 2019.
The registered office of Akaal Life Sciences is at House No. 638 Phase 3A, Sector 53, Mohali, Punjab, India – 160059.
Akaal Life Sciences operates in the pharma industry, in the drug formulation and development segment.
Akaal Life Sciences has open charges of ₹6.78 Lakh and no satisfied charges on record as per latest MCA filings.
Akaal Life Sciences can be reached at its registered office: House No. 638 Phase 3A, Sector 53, Mohali, Punjab, India – 160059.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
